Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression (TalarAVN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02289976
Recruitment Status : Unknown
Verified November 2014 by BG Trauma Center Ludwigshafen.
Recruitment status was:  Recruiting
First Posted : November 13, 2014
Last Update Posted : November 13, 2014
Sponsor:
Information provided by (Responsible Party):
BG Trauma Center Ludwigshafen

Brief Summary:
The purpose of this study is to determine if surgical angiogenesis performed in talar avascular necrosis by free microvascular bone grafts from the medial femoral condyle is a superior technique compared to core decompression and nonvascularized osseous autografts.

Condition or disease Intervention/treatment Phase
Avascular Necrosis of Bone Procedure: core decompression Not Applicable

Detailed Description:

The aim of this prospective randomized clinical trial is the comparison of two surgical treatment options for talar avascular necrosis (analogical to Ficat and Arlet stage II and III). The randomized study design allows direct comparability of the outcome after either core decompression and nonvascularized osseous autografting from the iliac crest or core decompression and osseous autografting with a free microvascular medial femoral condyle.

Talar avascular necrosis is caused by osseous malperfusion leading to malnutrition and destruction of the talar bone. The extend of this malperfusion is variable and can be categorized in 4 stages. The osseous defects can remain without consequences (stage I) or lead to irreversible talar destruction. The current treatment option for stage II and III is the core decompression followed by osseous auto grafting from the iliac crest. Reducing the intraosseal pressure and filling the drill holes with the nonvascularized bone graft can lead to reperfusion of the talus.

A new technique is to fill the drill hole with a vascularized bone graft from the medial femoral condyle, using microvascular anastomosis. This procedure has already been approved for the treatment of avascular necrosis and malperfusion of the carpus (lunate and scaphoid) as well as the femoral head.

Patients are examined preoperative as well as 3, 6 and 12 month after operation, documenting the active range of motion and pain sensation while resting and on activity. Well established scores like the AOFAS Ankle-Hindfoot Score and the Lower Extremity Functional Scale are used to get subjective and objective informations about patients' daily life and postoperative satisfaction. X-Rays are taken at the same stages. MRIs of the ankle joint with contrast agent are performed before as well as 6 and 12 months after surgery.

Statistical analysis is performed using the Statistical Package for the Social Sciences (SPSS). The Study protocol has been approved by the Ethics Commission of Rheinland-Pfalz. Interventions are done according to the declaration of Helsinki.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Talar Avascular Necrosis: Surgical Angiogenesis Compared to Core Decompression With Osseous Autografting
Study Start Date : February 2014
Estimated Primary Completion Date : November 2014
Estimated Study Completion Date : November 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: femoral condyle
Core decompression of the talar avascular necrosis followed by free microvascular femoral condyle grafting
Procedure: core decompression
Drilling of the avascular necrosis of the talus by 10mm drill under x-ray control

Active Comparator: core decompression
Core decompression and nonvascularized autograft from the iliac crest
Procedure: core decompression
Drilling of the avascular necrosis of the talus by 10mm drill under x-ray control




Primary Outcome Measures :
  1. Pain reduction [ Time Frame: pre operation; 3, 6, 12 months post operation ]
    measured by visual anloge scale


Secondary Outcome Measures :
  1. Revascularization of the talus in the MRI [ Time Frame: 6, 12 month post operation ]
    by ARCO-Criteria

  2. Lower Extremity Functional Scale [ Time Frame: pre operation; 3, 6, 12 month post operation ]
  3. American Orthopaedic Foot and Ankle Society (AOFAS-) Ankle-Hindfoot-Score [ Time Frame: pre operation; 3, 6, 12 month post operation ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients with talar avascular necrosis without response to non-surgical treatment (immobilization) and with need for surgical intervention (Ficat and Arlet stage II and III; Berndt and Harty stage II and III)

Exclusion Criteria:

  • talar avascular necrosis stage I (without need for surgical intervention)
  • surgical revascularization in the past
  • participation in a different study
  • pregnancy
  • peripheral artery occlusive disease
  • drug associated talar avascular necrosis
  • ongoing steroid therapy or chemo therapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02289976


Contacts
Layout table for location contacts
Contact: Victoria F Struckmann, MD 0049-17663158299 vfs@me.com
Contact: Thomas Kremer, Phd, MD 0049-162-68108913 thomas.kremer@bgu-ludwigshafen.de

Locations
Layout table for location information
Germany
BG Trauma Center Ludwigshafen Recruiting
Ludwigshafen, Rheinland-Pfalz, Germany, 67071
Contact: Victoria F Struckmann, MD    0049-176-63158299    vfs@me.com   
Contact: Thomas Kremer, PhD, MD    0049-621-68108913    thomas.kremer@bgu-ludwigshafen.de   
Sponsors and Collaborators
BG Trauma Center Ludwigshafen
Investigators
Layout table for investigator information
Study Director: Thomas Kremer, Phd, MD BG Trauma Center Ludwigshafen
Publications of Results:
Other Publications:
Layout table for additonal information
Responsible Party: BG Trauma Center Ludwigshafen
ClinicalTrials.gov Identifier: NCT02289976    
Other Study ID Numbers: BGU-01/14
First Posted: November 13, 2014    Key Record Dates
Last Update Posted: November 13, 2014
Last Verified: November 2014
Keywords provided by BG Trauma Center Ludwigshafen:
talar avascular necrosis
osteochondrosis dissecans
femoral condyle
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteonecrosis
Necrosis
Pathologic Processes
Bone Diseases
Musculoskeletal Diseases